Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Witte

Showing results (151-160 of 162) with videos related to

Pageof 17
Sort By:
Zeitschrift Fur Rheumatologie|November 6, 2025
[Management of systemic lupus erythematosus-Including secondary antiphospholipid syndrome, fertility and pregnancy : S3 guidelines of the German Society for Rheumatology and Clinical Immunology and the German Society for Neurology (DGN), German Society for Internal Medicine (DGIM), German Cardiac Society (DGK), Society for Thrombosis and Hemostasis Research (GTH), German Society for Hematology and Medical Oncology (DGHO), German Society for Pediatric and Adolescent Medicine (DGKJ), Society for Pediatric and Adolescent Rheumatology (GKJR), German Society for Nephrology (DGfN), German Society for Pneumology and Ventilation Medicine (DGP), German Rheumatism League National Association, Lupus Erythematosus Self-help Community, German Dermatological Society (DDG). Version: 1.2]J Mucke, H-J Anders, M Aringer, et al.
Zeitschrift Fur Rheumatologie|November 6, 2020
[S2k guidelines (executive summary): management of large-vessel vasculitis]J H Schirmer, P M Aries, K Balzer, et al.
Lupus|November 11, 2011
Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus reportM Aringer, H Burkhardt, G R Burmester, et al.
Zeitschrift Fur Rheumatologie|November 6, 2020
[S2k guidelines: management of large-vessel vasculitis]J H Schirmer, P M Aries, K Balzer, et al.
Genes and Immunity|June 15, 2007
Opposed independent effects and epistasis in the complex association of IRF5 to SLEI Ferreiro-Neira, M Calaza, E Alonso-Perez, et al.
Lupus|October 1, 2016
Breast cancer in systemic lupusS Bernatsky, R Ramsey-Goldman, M Petri, et al.
Annals of the Rheumatic Diseases|August 16, 2013
Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritisA Serrano, A Márquez, S L Mackie, et al.
Clinical and Experimental Immunology|April 24, 2013
The German national registry for primary immunodeficiencies (PID)B Gathmann, S Goldacker, M Klima, et al.
Annals of the Rheumatic Diseases|June 13, 2014
Influence of the IL17A locus in giant cell arteritis susceptibilityA Márquez, J Hernández-Rodríguez, M C Cid, et al.
Oncology|July 27, 2013
Breast cancer in systemic lupus erythematosusB Tessier Cloutier, A E Clarke, R Ramsey-Goldman, et al.
Pageof 17

Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Zeitschrift Fur Rheumatologie|November 6, 2025
[Management of systemic lupus erythematosus-Including secondary antiphospholipid syndrome, fertility and pregnancy : S3 guidelines of the German Society for Rheumatology and Clinical Immunology and the German Society for Neurology (DGN), German Society for Internal Medicine (DGIM), German Cardiac Society (DGK), Society for Thrombosis and Hemostasis Research (GTH), German Society for Hematology and Medical Oncology (DGHO), German Society for Pediatric and Adolescent Medicine (DGKJ), Society for Pediatric and Adolescent Rheumatology (GKJR), German Society for Nephrology (DGfN), German Society for Pneumology and Ventilation Medicine (DGP), German Rheumatism League National Association, Lupus Erythematosus Self-help Community, German Dermatological Society (DDG). Version: 1.2]J Mucke, H-J Anders, M Aringer, et al.
Zeitschrift Fur Rheumatologie|November 6, 2020
[S2k guidelines (executive summary): management of large-vessel vasculitis]J H Schirmer, P M Aries, K Balzer, et al.
Lupus|November 11, 2011
Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus reportM Aringer, H Burkhardt, G R Burmester, et al.
Zeitschrift Fur Rheumatologie|November 6, 2020
[S2k guidelines: management of large-vessel vasculitis]J H Schirmer, P M Aries, K Balzer, et al.
Genes and Immunity|June 15, 2007
Opposed independent effects and epistasis in the complex association of IRF5 to SLEI Ferreiro-Neira, M Calaza, E Alonso-Perez, et al.
Lupus|October 1, 2016
Breast cancer in systemic lupusS Bernatsky, R Ramsey-Goldman, M Petri, et al.
Annals of the Rheumatic Diseases|August 16, 2013
Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritisA Serrano, A Márquez, S L Mackie, et al.
Clinical and Experimental Immunology|April 24, 2013
The German national registry for primary immunodeficiencies (PID)B Gathmann, S Goldacker, M Klima, et al.
Annals of the Rheumatic Diseases|June 13, 2014
Influence of the IL17A locus in giant cell arteritis susceptibilityA Márquez, J Hernández-Rodríguez, M C Cid, et al.
Oncology|July 27, 2013
Breast cancer in systemic lupus erythematosusB Tessier Cloutier, A E Clarke, R Ramsey-Goldman, et al.
Pageof 17